Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00010517
Status:
COMPLETED
Last Update Posted:
2008-03-07
First Post:
2001-02-02
Brief Title:
Acupuncture in the Treatment of Depression
Sponsor:
National Center for Complementary and Integrative Health NCCIH
Organization:
National Center for Complementary and Integrative Health NCCIH
Study Overview
Official Title:
Acupuncture in the Treatment of Depression
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The current large randomized placebo-controlled trial is testing the ability of acupuncture to treat major depression The study is unique in that treatment effects will be from the perspective of both Western psychiatry and Chinese medicine
Detailed Description:
Depression is an unfortunately common condition for which people often seek alternative non-Western treatments perhaps because conventional treatments do not consistently provide lasting relief A pilot study Allen Schnyer and Hitt 1998 suggests that acupuncture a popular but under-researched alternative treatment derived from Chinese medicine holds sufficient promise as a treatment for depression to warrant a larger-scale clinical trial The investigators propose to conduct a larger-scale test of the efficacy of acupuncture in this trial Because relapse and recurrence of Major Depression are quite common the investigators also will assess the clinical status of participants for 18 months after treatment concludes In the first phase of this double-blind randomized clinical trial 150 men and women meeting criteria for Major Depression will be randomly assigned to a treatment approach or to a waitlist control All participants will ultimately receive acupuncture designed to address their own particular constellation of depressive symptoms At the end of this first phase blind assessments will be used to compare treatment effects from the perspectives of both Western psychiatry and Chinese medicine After this treatment phase participants will be assessed several times over the next 18 months The study is designed to evaluate the efficacy and clinical significance of acupuncture as a treatment for Major Depression and to examine the convergence of Western-based and Chinese-medicine-based outcome measures Finally the study will determine whether changes in energetic pattern mediate changes in Western defined depression severity and explore whether patient and history variables predict responses to acupuncture treatments
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01AT000001-01 | NIH | None | httpsreporternihgovquickSearchR01AT000001-01 |